Skip to main content
. 2021 Mar 19;100(11):e24954. doi: 10.1097/MD.0000000000024954

Table 2.

Diagnostic tests for the case groups.

Laboratory tests frequency (%)
Anti-tTG SBB HLA result
Patient groups Positive Negative Positive Negative Positive Negative Notes
A 3 [8.5%] 27 [77.1%]
B 29 [82.8%] 6 [17.1%] 20 [57.1%] 3 [8.5%] 35 [100%] 0
C 24 [68%] 11 [31%] 3 [8.5%] 6 [17.1%] 24 [68%] 11 [31.4%] 24 had CD
D 9 [25.7%] 26 [74.2%] 4 [11.4%] 0 32 [91.4%] 3 [8.6%] 9 had CD
E 9 [25.7%] 26 [74.2%] None had CD

Group A: control; Group B: diagnosed cases of celiac disease; Group C: patients with celiac-like symptoms; Group D: type 1 diabetes patients with celiac-like symptoms; Group E: type 1 diabetes patients.

HLA-typing: alleles detected: HLA-DQA1∗05, DQB1∗02, and/or DQB1∗03:02.

Anti-tTG = anti tissue transglutaminase; CD = celiac disease; SBB = small bowel biopsy.